Show
Sort by
-
Association of comorbidities in spondyloarthritis with poor function, work disability and quality of life : results from the Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis study
-
Work outcome in patients with ankylosing spondylitis : results from a 12-year followup of an international study
-
Do extra-articular manifestations influence outcome in ankylosing spondylitis? : 12-year results from OASIS
-
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC) : long-term extension over 7 years with focus on clinical efficacy and safety
-
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies : 2015 update
-
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents?: a long-term observational study using MRI and conventional radiography
-
The assessment of spondyloarthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
-
The European Ankylosing Spondylitis Infliximab Cohort (EASIC) : a European multicentre study of long-term outcomes in patients with ankylosing spondylitis treated with infliximab
-
The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal
-
The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection
-
Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine
-
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of Spondyloarthritis international Society (ASAS)
-
How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
-
Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis
-
Determinants of hyperkyphosis in patients with ankylosing spondylitis
-
Serum matrix metalloproteinase 3 is an independent predictor of structural damage progession in patients with ankylosing spondylitis (AS)
-
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis
-
Occurrence and 2-year progression of syndesmophytes in a prevalence cohort of patients with ankylosing spondylitis (AS)
-
Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?
-
The SF-6D differentiates less in the lower ranges of the patient's utility when compared with the EQ-5D but has a better reliability and sensitivity to change
-
Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives
-
Parameters contributing to inflammatory back pain (IBP) according to experts
-
Assessment of agreement of expert opinion on clinical features in axial spondyloarthritis (SpA)
-
The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the bath ankylosing spondylitis disease activity index
-
Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order
-
Measurement of spinal mobility in ankylosing spondylitis: Comparison of occiput-to-wall and tragus-to-wall distance
-
Assessment of enthesitis in ankylosing spondylitis
-
Costs of ankylosing spondylitis in three European countries: the patient's perspective
-
Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries
-
Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.